• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates HepVu Releases Updated Treatment Restrictions Data

HepVu Releases Updated Treatment Restrictions Data

August 25, 2022

Today, HepVu added updated data and comparison maps visualizing Hepatitis C treatment restrictions at the state-level from 2017 to 2022, utilizing insights and research findings provided by Hepatitis C: State of Medicaid Access, a joint project by the Center for Health Law and Policy Innovation (CHLPI) of Harvard Law School and the National Viral Hepatitis Roundtable (NVHR).

Share Facebook Twitter Pinterest LinkedIn

Among the updated data and maps is a new map visualizing retreatment restrictions, showcasing which state Medicaid programs have more severe restrictions for patients seeking retreatment for Hepatitis C. Additionally, these treatment restrictions data are updated on HepVu’s state profiles, where users can get a complete picture of the viral hepatitis epidemic in their state.

Treatment restrictions are non-medically indicated criteria limiting access to lifesaving medications. When highly effective and curative direct-acting antivirals (DAAs) were introduced to treat Hepatitis C nearly a decade ago, many state Medicaid programs created restrictions for patients to access the new medications as a cost-saving measure. These treatment restrictions create barriers to life-saving treatment, perpetuate stigma, and undermine public health efforts to address the transmission of Hepatitis C.

Five major types of restrictions on Hepatitis C treatment employed by state Medicaid programs include:

  1. Fibrosis Level Treatment Restrictions – These restrictions require patients to reach a certain stage of fibrosis (liver scarring) before being able to access treatment for Hepatitis C
  2. Substance Use Treatment Restrictions – These restrictions require patients to abstain from using alcohol and/or drugs prior to or during treatment, or require providers to counsel their patients regarding drug or alcohol before being able to access treatment.
  3. Prescriber Treatment Restrictions – These restrictions require a prescription for treatment to be issued by or in consultation with a specialist.
  4. Prior Authorization – These restrictions require patients to receive prior approval in order to receive treatment.
  5. Retreatment Restrictions – These restrictions require more severe restrictions for patients seeking retreatment.

While much progress has been made, work towards eliminating barriers to care and increasing access to Hepatitis C treatment must continue, especially for medically underserved populations such as communities of color and people who inject drugs. To get involved and help advocate to eliminate these treatment restrictions, explore Hepatitis C: State of Medicaid Access.

For more information on the data source and limitations, see our Data Methods.

Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn

To learn more about Hepatitis C treatment restrictions, explore HepVu’s resources:

  • Visualize the current landscape of Hepatitis C treatment restrictions at the state-level with HepVu’s interactive maps.
  • Explore our local data profiles to learn about Hepatitis C treatment restrictions in your state.
  • Read expert-led Q&As on Hepatitis C treatment restrictions:
    • CHLPI and NVHR on the State of Hepatitis C Treatment Restrictions
    • Patient Perspective on the Challenges of Treatment Restrictions in Hepatitis C Care
  • Find available viral hepatitis testing and care services near you with HepVu’s service locators.
  • Share our infographics with your networks to raise awareness.
  • Download our data sets.

Most Read

Hepatitis C Treatment Restrictions
Combatting Hepatitis C Among People Who Use Drugs in Appalachia
What’s New in Viral Hepatitis – February
Share Facebook Twitter LinkedIn Email

Keep Reading

August 11, 2022

Chari Cohen On The Importance Of Vaccinating Against Hepatitis B

Read More

August 11, 2022

Deeper Look: Immunization

Read More

July 28, 2021

Jim Macrae on Health Disparities in Viral Hepatitis Elimination

Read More

August 11, 2022

What's New in Viral Hepatitis - August 2022

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.